SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Oxysure Systems Inc (OTCMKTS:OXYS) is set to disclose its financial report for the quarter ending June 30, 2015 on August 19, 2015. The company had recorded ten consecutive quarter of strong sales growth. In 4Q2014, the revenue jumped 35% to $2.4 million driven by an 83% increases in sales in the U.S.

The gross margin came at 56% on an adjusted basis; cash reserve was at $647,000 and G&A expense stood at $1.75 million in 4Q2014. During the period, the company paid down all of its capital leases. Out of the last ten growth quarters, five quarters witnessed triple-digit growth while four quarters registered double-digit growth. Oxysure has no intention of slowing down in 1Q2015.

The results

In addition to Oxysure, the other companies that are set to report their financial results on August 19, 2015 are Lowe’s Companies, Inc. (NYSE:LOW) and Target Corporation (NYSE:TGT). Lowe’s recently introduced its latest tool to assist Pro clients save money, time and operate their businesses efficiently. The new tool is an enhanced upgraded site. The Pro clients can make and manage the purchases of over 500,000 items to run their operations from the convenience of a Smartphone, computer or tablet and can choose to purchase from online platform and pick-up in-store.

Target Corporation top line growth will largely be dependent on the growth of digital sales and the number of new stores. In order to increase the online sales, the company is testing single day deliveries.  The company operates in the retail segment and therefore is set to benefit from the weak global oil prices. Also, the economic data like the jobless claims and consumer spending were largely in favour of the retail companies.

The expectations

During 4Q2014 results, the management of Oxysure stated that their growth strategy comprises two parts. The first part is organic growth and the second part covers a strategic business combination to create leverage.